Back
Universe Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
UPC
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Buy
58
UPC
Universe Pharmaceuticals
Last Price:
2.14
Seasonality Move:
-40.69%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Universe Pharmaceuticals Price Quote
$2.14
-0.05 (-2.28%)
(Updated: April 19, 2024 at 6:55 PM ET)
Universe Pharmaceuticals Key Stats
Buy
58
Universe Pharmaceuticals (UPC)
is a Buy
Day range:
$1.84 - $2.29
52-week range:
$0.75 - $5.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.25
P/B ratio:
0.2%
Volume:
266.1K
Avg. volume:
116.5K
1-year change:
-32.41%
Market cap:
$8M
Revenue:
$32.3M
EPS:
$-1.7
How Much Does Universe Pharmaceuticals Make?
-
How Much Are Universe Pharmaceuticals's Sales Annually?
UPC Revenues are $32.3M -
How Much Profit Does Universe Pharmaceuticals's Make A Year?
UPC net income is -$6.2M
Is Universe Pharmaceuticals Growing As A Company?
Data Unavailable
Universe Pharmaceuticals Stock Price Performance
-
Did Universe Pharmaceuticals Stock Go Up Last Month?
Universe Pharmaceuticals share price went up by 41.29% last month -
Did UPC's Share Price Rise Over The Last Year?
UPC share price fell by -32.41% over the past 1 year
What Is Universe Pharmaceuticals 52-Week High & Low?
-
What Is Universe Pharmaceuticals’s 52-Week High Share Price?
Universe Pharmaceuticals has traded as high as $5.88 over the past 52 weeks -
What Is Universe Pharmaceuticals’s 52-Week Low Share Price?
Universe Pharmaceuticals has traded as low as $0.75 over the past 52 weeks
Universe Pharmaceuticals Price To Free Cash Flow
-
Is Universe Pharmaceuticals Stock Overvalued?
Universe Pharmaceuticals is trading at a price to free cash flow ratio of 7.38 -
Is Universe Pharmaceuticals Stock Undervalued?
Universe Pharmaceuticals EV to Free Cash Flow ratio is -4.68 -
What Is Universe Pharmaceuticals’s Price Earnings Growth Ratio?
UPC PEG ratio is 0.00 -
Is Universe Pharmaceuticals Trading At A Premium To Earnings?
Universe Pharmaceuticals EV to EBIT ratio is 0.00
Is It Risky To Buy Universe Pharmaceuticals?
-
How Much Debt Does Universe Pharmaceuticals Have?
Total long term debt quarterly is $5.5M -
How Much Cash Does Universe Pharmaceuticals Have?
Cash and short term investments quarterly total is $18.5M -
What Is Universe Pharmaceuticals’s Book Value Per Share?
Book value per share is 10.84
Is Universe Pharmaceuticals Cash Flow Positive?
-
What Is UPC Cash Flow From Operations?
Cash flow from operations (TTM) is $1.1M -
What Is Universe Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.4M -
What Is Universe Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$44.2K
Universe Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
UPC return on invested capital is -12.61% -
What Is Universe Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -10.09% -
What Is UPC Return On Equity?
ROE is a measure of profitability and is -13.89%
Universe Pharmaceuticals Earnings Date & Stock Price
-
What Is Universe Pharmaceuticals's Stock Price Today?
A single share of UPC can be purchased today for 2.19 -
What Is Universe Pharmaceuticals’s Stock Symbol?
Universe Pharmaceuticals trades on the nasdaq under the ticker symbol: UPC -
When Is Universe Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Universe Pharmaceuticals is scheduled on January 30, 2025 -
When Is UPC's next ex-dividend date?
Universe Pharmaceuticals's next ex-dividend date is April 20, 2024 -
How To Buy Universe Pharmaceuticals Stock?
You can buy Universe Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Universe Pharmaceuticals Competitors
-
Who Are Universe Pharmaceuticals's Competitors?
Below is a list of companies who compete with Universe Pharmaceuticals or are related in some way:
Universe Pharmaceuticals Dividend Yield
Data Unavailable
Universe Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |